For research use only. Not for therapeutic Use.
R-724(Cat No.:I035394)is an investigational compound that has been studied for its potential therapeutic applications in the field of oncology. It functions by targeting specific molecular pathways involved in tumor growth, angiogenesis, and metastasis. R-724 is believed to inhibit certain kinases or signaling molecules crucial for cancer cell proliferation and survival. Preclinical studies suggest it may have antitumor activity, particularly in certain types of cancer. Further clinical trials are required to assess its safety, efficacy, optimal dosing, and potential as a treatment for solid tumors or hematologic malignancies.
Catalog Number | I035394 |
CAS Number | 185052-15-7 |
Synonyms | R-724; R 724; R724; |
Molecular Formula | C52H72N12O11 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-methylpentanoic acid |
InChI | InChI=1S/C52H72N12O11/c1-4-31(2)44(51(74)75)62-46(69)38(27-33-20-21-34-15-8-9-16-35(34)25-33)60-47(70)39(30-65)61-45(68)37(26-32-13-6-5-7-14-32)59-43(67)29-57-48(71)40-18-11-23-63(40)50(73)41-19-12-24-64(41)49(72)36(58-42(66)28-55-3)17-10-22-56-52(53)54/h5-9,13-16,20-21,25,31,36-41,44,55,65H,4,10-12,17-19,22-24,26-30H2,1-3H3,(H,57,71)(H,58,66)(H,59,67)(H,60,70)(H,61,68)(H,62,69)(H,74,75)(H4,53,54,56)/t31-,36-,37-,38+,39-,40-,41-,44-/m0/s1 |
InChIKey | LSLTWPDKBWZFBR-WFELYJBBSA-N |
SMILES | CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCCN=C(N)N)NC(=O)CNC |